BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37344847)

  • 1. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
    Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
    Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
    Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
    Zhong X; Lin Y; Zhang W; Bi Q
    Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
    Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
    Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
    Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
    Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
    J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival and prognosis of postoperative breast cancer brain metastasis: a population-based retrospective analysis.
    Nie Y; Ying B; Lu Z; Sun T; Sun G
    Chin Med J (Engl); 2023 Jul; 136(14):1699-1707. PubMed ID: 37257115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery.
    Zheng Y; Geng D; Yu T; Xia W; She D; Liu L; Yin B
    Acta Radiol; 2021 Sep; 62(9):1208-1216. PubMed ID: 32910684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
    Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
    Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
    Leone JP; Lee AV; Brufsky AM
    Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer.
    Xiao W; Li X; Yang A; Chen B; Zheng S; Zhang G; Deng W; Liao N
    Front Oncol; 2020; 10():431. PubMed ID: 32309214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
    Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
    World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
    Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
    Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases.
    Mills MN; Thawani C; Figura NB; Oliver DE; Soyano AE; Etame A; Robinson TJ; Liu JK; Vogelbaum MA; Forsyth PA; Czerniecki BJ; Soliman HH; Han HS; Yu HM; Ahmed KA
    J Neurooncol; 2021 May; 152(3):591-601. PubMed ID: 33742358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
    Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
    World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases.
    Chen X; Bai X; Xie X; Huang J; Chen L; Song L; Lan X; Zhang Q; Guo J; Du C
    Ann Med; 2023 Dec; 55(1):2218647. PubMed ID: 37260331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.